ngiotensin II Receptors From Peritransplantation hrough First-Year Post-Transplantation nd the Risk of Transplant Coronary Artery Disease

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial.

  2003cited by this paper
• Myocardial ischemic-fibrotic injury after human heart transplantation is associated with increased progression of vasculopathy, decreased cellular rejection and poor long-term outcome.

  2002cited by this paper
• Immunosuppressive treatment protects against angiotensin II-induced renal damage.

  2002cited by this paper
• ACE-gene polymorphism is associated with the development of allograft vascular disease in heart transplant recipients.

  2000cited by this paper
• Expression of angiotensin II and interleukin 6 in human coronary atherosclerotic plaques: potential implications for inflammation and plaque instability.

  2000cited by this paper
• Maximally recommended doses of angiotensin-converting enzyme (ACE) inhibitors do not completely prevent ACE-mediated formation of angiotensin II in chronic heart failure.

  2000cited by this paper
• Cardiac allograft vasculopathy

  2000cited by this paper
• Progression of cardiac allograft vascular disease as assessed by serial intravascular ultrasound: correlation to immunological and non-immunological risk factors

  2000cited by this paper
• Angiotensin II plays a pathogenic role in immune-mediated renal injury in mice.

  1999cited by this paper
• Angiotensin II regulates cellular immune responses through a calcineurin-dependent pathway.

  1999cited by this paper
• Donor ACE gene polymorphism: a genetic risk factor for accelerated coronary sclerosis following cardiac transplantation.

  1998cited by this paper
• Heart transplant coronary artery disease detected by coronary angiography: a multiinstitutional study of preoperative donor and recipient risk factors. Cardiac Transplant Research Database.

  1998cited by this paper
• Angiotensin II type 2 receptor mediates vascular smooth muscle cell apoptosis and antagonizes angiotensin II type 1 receptor action: an in vitro gene transfer study.

  1998cited by this paper
• Angiotensin II and gene expression in the kidney.

  1998cited by this paper
• Salt induces vascular AT1 receptor overexpression in vitro and in vivo.

  1998cited by this paper
• Differential Distribution of Angiotensin AT 2 Receptors in the Normal and Failing Human Heart 1

  1997cited by this paper
• Candesartan cilexetil reduces chronic renal allograft injury in Fisher → Lewis rats

  1997cited by this paper
• Coronary Artery Disease in the Transplanted Heart: Why Does It Happen and What Can We Do About It?

  1996cited by this paper
• Occult and frequent transmission of atherosclerotic coronary disease with cardiac transplantation. Insights from intravascular ultrasound.

  1995cited by this paper
• Incidence and progression of transplant coronary artery disease over 1 year: results of a multicenter trial with use of intravascular ultrasound. Multicenter Intravascular Ultrasound Transplant Study Group.

  1995cited by this paper
• Presence of severe intimal thickening by intravascular ultrasonography predicts cardiac events in cardiac allograft vasculopathy.

  1995cited by this paper
• An intravascular ultrasound study of the influence of angiotensin-converting enzyme inhibitors and calcium entry blockers on the development of cardiac allograft vasculopathy.

  1995cited by this paper
• Influence of graft rejection on incidence of accelerated graft coronary artery disease: a new approach to analysis.

  1993cited by this paper
• The Registry of the International Society for Heart and Lung Transplantation: tenth official report--1993.

  1993cited by this paper
• Histopathology of graft coronary disease.

  1992cited by this paper
• Cardiac allograft vasculopathy: relationship with acute cellular rejection and histocompatibility.

  1992cited by this paper
• Characterization of angiotensin II receptor subtypes in the rat spleen.

  1992cited by this paper
• Prevalence of accelerated coronary artery disease in heart transplant survivors. Comparison of cyclosporine and azathioprine regimens.

  1989cited by this paper
• The meaning and use of the area under a receiver operating characteristic (ROC) curve.

  1982cited by this paper
• National Heart, Lung, and Blood Institute Coronary Artery Surgery Study. A multicenter comparison of the effects of randomized medical and surgical treatment of mildly symptomatic patients with coronary artery disease, and a registry of consecutive patients undergoing coronary angiography.

  1981cited by this paper
• Binding sites for angiotensin II in human mononuclear leucocytes.

  1978cited by this paper

• No citing papers are available for this paper.